Editorial
doi: 10.1007/s12098-022-04296-9.
Epub 2022 Jun 22.
Fibroblast Growth Factor 23 and Chronic Kidney Disease in Children: Is It the Heart of the Matter?
Affiliations
- PMID: 35731500
- DOI: 10.1007/s12098-022-04296-9
Item in Clipboard
Editorial
Fibroblast Growth Factor 23 and Chronic Kidney Disease in Children: Is It the Heart of the Matter?
Indian J Pediatr.
2022 Sep.
No abstract available
Comment on
-
Fibroblast Growth Factor 23 Level and Cardiovascular Parameters in Children with Chronic Kidney Disease.Indian J Pediatr. 2022 Sep;89(9):865-871. doi: 10.1007/s12098-021-03927-x. Epub 2021 Nov 12. Indian J Pediatr. 2022. PMID: 34767187
Similar articles
-
Role of fibroblast growth factor 23 in patients with chronic kidney disease.Chin Med J (Engl). 2020 Oct 20;134(4):404-406. doi: 10.1097/CM9.0000000000001148. Chin Med J (Engl). 2020. PMID: 33093281 Free PMC article. No abstract available.
-
Fibroblast growth factor 23 (FGF23) induces ventricular arrhythmias and prolongs QTc interval in mice in an FGF receptor 4-dependent manner.Am J Physiol Heart Circ Physiol. 2021 Jun 1;320(6):H2283-H2294. doi: 10.1152/ajpheart.00798.2020. Epub 2021 Apr 30. Am J Physiol Heart Circ Physiol. 2021. PMID: 33929896 Free PMC article.
-
Short-Term Effects of Potassium Chloride Supplementation on Fibroblast Growth Factor 23 and Phosphate in CKD.Clin J Am Soc Nephrol. 2023 Jan 1;18(1):99-101. doi: 10.2215/CJN.09340822. Clin J Am Soc Nephrol. 2023. PMID: 36357127 Free PMC article. No abstract available.
-
Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials.Ann Palliat Med. 2022 Apr;11(4):1264-1277. doi: 10.21037/apm-21-1943. Epub 2021 Nov 2. Ann Palliat Med. 2022. PMID: 34775773
-
Simultaneous management of disordered phosphate and iron homeostasis to correct fibroblast growth factor 23 and associated outcomes in chronic kidney disease.Curr Opin Nephrol Hypertens. 2020 Jul;29(4):359-366. doi: 10.1097/MNH.0000000000000614. Curr Opin Nephrol Hypertens. 2020. PMID: 32452919 Free PMC article. Review.
Cited by
-
Role of klotho and fibroblast growth factor 23 in arterial calcification, thickness, and stiffness: a meta-analysis of observational studies.Sci Rep. 2024 Mar 8;14(1):5712. doi: 10.1038/s41598-024-56377-8. Sci Rep. 2024. PMID: 38459119 Free PMC article.
References
-
- Harada R, Hamasaki Y, Okuda Y, Hamada R, Ishikura K. Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies. Pediatr Nephrol. 2021. https://doi.org/10.1007/s00467-021-05145-1 . - DOI - PubMed
-
- Vogt I, Haffner D, Leifheit-Nestler M. FGF23 and phosphate: cardiovascular toxins in CKD. Toxins (Basel). 2019;11:647. - DOI
-
- Singh G, Mishra OP, Abhinay A, et al. Fibroblast growth factor 23 level and cardiovascular parameters in children with chronic kidney disease. Indian J Pediatr. 2021. https://doi.org/10.1007/s12098-021-03927-x . - DOI - PubMed - PMC
-
- Stöhr R, Schuh A, Heine GH, Brandenburg V. FGF23 in cardiovascular disease: innocent bystander or active mediator? Front Endocrinol (Lausanne). 2018;9:351. - DOI
-
- Marthi A, Donovan K, Haynes R, et al. Fibroblast growth factor-23 and risks of cardiovascular and noncardiovascular diseases: a meta-analysis. J Am Soc Nephrol. 2018;29:2015–27. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
